Innovative Light Therapy Targets Tumors While Preserving Healthy Tissue
In the ongoing battle against cancer, there is an urgent need for treatments that limit the harmful side effects associated with conventional therapies like chemotherapy and radiotherapy, which indiscriminately impact both malignant and normal cells.
Researchers from the University of Texas at Austin and the University of Porto in Portugal have taken a significant step forward by introducing materials that can transform near-infrared (NIR) light into heat to specifically target cancerous cells, minimizing damage to surrounding healthy tissue. These materials consist of ultra-thin tin oxide (SnO) nanoflakes, each measuring less than 20 nanometers thick, where a nanometer is one-billionth of a meter.
Detailed in a recent journal publication, these findings pave the way for advanced photothermal therapy—a type of light-based treatment that eradicates cancer cells using heat. This technique involves infiltrating cancerous tissues with light-absorbing materials such as the developed SnO nanoflakes, which can specifically accumulate in tumors. When these nanoflakes are exposed to light at a specific wavelength, they produce sufficient heat to destroy cancer cells without harming healthy tissues.
The SnO nanoflakes represent a promising advancement due to their improved thermal efficiency, compatibility with biological systems, and cost-effectiveness compared to existing materials used in similar treatments.
Jean Anne Incorvia, a leading figure in this research and an engineering professor at the University of Texas, emphasized their objective: "We aimed to design a treatment that offers both efficacy and safety. By integrating LED technology with SnO nanoflakes, we’ve crafted a method for selectively targeting cancerous cells, sparing the healthy ones."
Testing and Affordability
To validate their innovation, the team devised a near-infrared LED (NIR-LED) system that emits light at 810 nanometers, a wavelength friendly to living tissues. Unlike conventional laser systems, these NIR-LEDs provide consistent lighting, posing less risk of overheating, and are economically feasible. The entire experimental setup, capable of processing 24 samples simultaneously, was developed at a cost of around $530, making it an accessible option for broad biomedical research.
This method has shown promising results; exposure to NIR light for as short as 30 minutes was able to annihilate up to 92% of skin cancer cells and half of colorectal cancer cells, while leaving healthy cells unscathed—highlighting the precision and safety of the treatment.
Future Implications
While further testing and clinical trials are crucial, this work indicates that SnO nanoflakes, combined with specific lighting, could become a viable and low-cost photothermal option for cancer treatment. Artur Pinto, another project leader from the University of Porto's School of Engineering, expressed a hopeful vision: "Our ultimate aim is to make this technology reachable to patients globally, especially in underserved areas, with ease of access and fewer side effects."
Regarding skin cancers, Pinto elaborated on the potential for treatment to occur outside clinical settings, saying, "One day, we foresee this therapy being transferred to patients' homes. A wearable device could be applied post-surgery to eradicate any residual cancerous cells, thus significantly lowering the chances of recurrence."



Leave a Reply